Skip to main content

Roche’s virtual event following ASH 2021

Roche has hosted a virtual event on Wednesday, 15 December 2021.

Agenda
WelcomeKarl Mahler, Head of Investor Relations
Hematology Franchise OverviewPeter Ahnesorg, Franchise Head Hematology
Review of Key Clinical Data Presented at ASH: Hemlibra, mosun, glofit, cevostamabCharles Fuchs, Senior Vice President - Global Head Of Oncology And Hematology Product Development
Presentation of POLARIX data Franck Morschhauser, MD, PhD, Professor of Hematology, University of Lille; President of LYSA, LYSARC
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Download Presentation

PDF

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.